Sisram Medical (SEHK:1696) - Stock Price, News & Analysis

1696 Stock Overview

Engages in the research, design, development, manufacture, and sales of medical aesthetics and dental equipment, home use devices, injectables, and cosmeceuticals products in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa.

About the company

1696 fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	4/6
Past Performance	2/6
Financial Health	5/6
Dividends	3/6

Rewards

Trading at 26.1% below our estimate of its fair value

Earnings are forecast to grow 22.35% per year

Trading at good value compared to peers and industry

Risk Analysis

Profit margins (6.6%) are lower than last year (10.9%)

Unstable dividend track record

Sisram Medical Ltd Competitors

Gaush Meditech

SEHK:2407

HK$1.6b

PW Medtech Group

SEHK:1358

HK$1.7b

Acotec Scientific Holdings

SEHK:6669

HK$2.4b

Modern Dental Group

SEHK:3600

HK$3.5b

Price History & Performance

Summary of all time highs, changes and price drops for Sisram Medical
Historical stock prices
Current Share Price	HK$2.95
52 Week High	HK$7.74
52 Week Low	HK$2.79
Beta	1.4
11 Month Change	-1.67%
3 Month Change	-25.13%
1 Year Change	-59.03%
33 Year Change	-79.63%
5 Year Change	-16.90%
Change since IPO	-63.67%

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Aug 23

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Jul 24

Recent updates

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Aug 23

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Jul 24

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Jun 17

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

May 30

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Apr 19

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Mar 01

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Jan 12

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Dec 21

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Dec 01

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Oct 14

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Sep 28

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Aug 25

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Aug 01

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

May 19

Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

May 03

If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Apr 11

Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Mar 17

Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Nov 22

Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Aug 22

Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Jul 27

Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

Jun 24

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Apr 16

Shareholder Returns

	1696	HK Medical Equipment	HK Market
7D	-9.2%	-4.4%	0.3%
1Y	-59.0%	-46.2%	4.0%

Return vs Industry: 1696 underperformed the Hong Kong Medical Equipment industry which returned -46.2% over the past year.

Return vs Market: 1696 underperformed the Hong Kong Market which returned 4% over the past year.

Price Volatility

Is 1696's price volatile compared to industry and market?
1696 volatility
1696 Average Weekly Movement	5.8%
Medical Equipment Industry Average Movement	6.5%
Market Average Movement	6.3%
10% most volatile stocks in HK Market	13.1%
10% least volatile stocks in HK Market	3.3%

Stable Share Price: 1696's share price has been volatile over the past 3 months.

Volatility Over Time: 1696's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2013	1,026	Lior Dayan	www.sisram-medical.com

Sisram Medical Ltd engages in the research, design, development, manufacture, and sales of medical aesthetics and dental equipment, home use devices, injectables, and cosmeceuticals products in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio for various wellness businesses, including hair removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodelling injectables, personal care, and aesthetic dentistry, trans epidermal delivery, cellulite treatment, stretch marks, vascular and pigmented lesions, hydradermabrasion, blepharoplasty-non surgical eyelid lift, liposuction, feminine health, and sexual rehabilitation. The company also manufactures, distributes, and sells medical equipment.

Sisram Medical Ltd Fundamentals Summary

How do Sisram Medical's earnings and revenue compare to its market cap?
1696 fundamental statistics
Market cap	HK$1.38b
Earnings (TTM)	HK$183.60m
Revenue (TTM)	HK$2.78b

7.5x

P/E Ratio

0.5x

P/S Ratio

Is 1696 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1696 income statement (TTM)
Revenue	US$356.40m
Cost of Revenue	US$136.86m
Gross Profit	US$219.54m
Other Expenses	US$195.99m
Earnings	US$23.55m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.05
Gross Margin	61.60%
Net Profit Margin	6.61%
Debt/Equity Ratio	1.1%

How did 1696 perform over the long term?

See historical performance and comparison

Dividends

5.4%

Current Dividend Yield

30%

Payout Ratio

Does 1696 pay a reliable dividends?

See 1696 dividend history and benchmarks

When do you need to buy 1696 by to receive an upcoming dividend?
Sisram Medical dividend dates
Ex Dividend Date	Aug 26 2024
Dividend Pay Date	Sep 09 2024
Days until Ex dividend	1 day
Days until Dividend pay date	15 days

Does 1696 pay a reliable dividends?

See 1696 dividend history and benchmarks

1696 Stock Overview

Rewards

Risk Analysis

Sisram Medical Ltd Competitors

SEHK:2407

HK$1.6b

SEHK:1358

HK$1.7b

SEHK:6669

HK$2.4b

SEHK:3600

HK$3.5b

Price History & Performance

Recent News & Updates

First half 2024 earnings released: EPS: US$0.023 (vs US$0.04 in 1H 2023)

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Dividend of HK$0.16 announced

Sisram Medical Ltd to Report First Half, 2024 Results on Aug 21, 2024

Sisram Medical Ltd Declares A Final Dividend, Payable on or Around 9 September 2024

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Recent updates

First half 2024 earnings released: EPS: US$0.023 (vs US$0.04 in 1H 2023)

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Dividend of HK$0.16 announced

Sisram Medical Ltd to Report First Half, 2024 Results on Aug 21, 2024

Sisram Medical Ltd Declares A Final Dividend, Payable on or Around 9 September 2024

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Sisram Medical Ltd, Annual General Meeting, Jun 24, 2024

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023

Sisram Medical Ltd to Report Fiscal Year 2023 Results on Mar 20, 2024

Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Investor sentiment deteriorates as stock falls 20%

Now 21% overvalued

Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Sisram Medical Ltd Announces the Registration Application of Profhilo

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Investor sentiment improves as stock rises 19%

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

First half 2023 earnings released: EPS: US$0.04 (vs US$0.044 in 1H 2022)

Upcoming dividend of HK$0.17 per share at 2.3% yield

Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Sisram Medical Ltd Announces Final Ordinary Dividend for the Year Ended December 31, 2022, Payable 07 September 2023

Sisram Medical Announces the Launch of Alma Veil for the U.S. Market

Sisram Medical Ltd. Receives the Clearance from the U.S. Food and Drug Administration

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Investor sentiment improves as stock rises 16%

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

Sisram Medical Ltd, Annual General Meeting, Jun 28, 2023

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Investor sentiment improves as stock rises 18%

Full year 2022 earnings released: EPS: US$0.086 (vs US$0.069 in FY 2021)

Investor sentiment deteriorates as stock falls 16%

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 19%

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Sisram Medical Ltd Announces Resignation of Mr. Guojun Bu from the Position of Executive Director of the Company with Effect from January 1, 2023

Investor sentiment improved over the past week

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Investor sentiment improved over the past week

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Less than half of directors are independent

Investor sentiment improved over the past week

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Investor sentiment deteriorated over the past week

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Sisram Medical Ltd Provides Revenue Guidance for the Year 2022

First half 2022 earnings released: EPS: US$0.044 (vs US$0.037 in 1H 2021)

Sisram Medical Ltd SHARE to Be Deleted from OTC Equity

Upcoming dividend of HK$0.16 per share